Cannabist Co. Holdings Aktie Logo
CA13765Y1034
A3EV8J
CBST.NE

Cannabist Co. Holdings Aktie

A carregar cotações...

Previsão

Comprar
  1
Manter
  0
Vender
  0

  • The Cannabist Company sells Virginia business to Curaleaf for $110 million

    The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Mais em de.investing.com


  • Cannabist Company reports revenue decline and falling EBITDA in Q3 2025

    Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Mais em de.investing.com


  • Cannabist Company reports revenue decline and share price loss due to restructuring

    Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Mais em de.investing.com

Dados financeiros da empresa

No último trimestre, Cannabist Co. Holdings Aktie registou receitas de € 68,1 mi e um ganho líquido de -€ 12,15 mi
(EUR) setembro de 2025
YoY
Receitas 68,1 mi -
Ganho bruto 19,52 mi -
Ganho líquido -12,15 mi -
EBITDA 6,65 mi -

Dados fundamentais

Métrica Valor
Capitalização bolsista
€ 12,92 mi
Número de ações
497,46 mi
Máximo/mínimo de 52 semanas
€ 0,14 - € 0,0178
Dividendos Não
Beta
1,05
PER (PE Ratio)
-0,15
PEG (PEG Ratio)
0,00
P/VC (PB Ratio)
-0,10
P/V (PS Ratio)
0,09

Perfil da empresa

The Cannabist Company Holdings Inc. dedica-se ao cultivo, fabrico e fornecimento de produtos e serviços relacionados com cannabis nos Estados Unidos e internacionalmente. A empresa oferece produtos que abrangem flores, comestíveis, óleos e comprimidos sob as marcas Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press e Amber. Detém licenças em 17 jurisdições nos Estados Unidos. A empresa era anteriormente conhecida como Columbia Care Inc. e mudou o seu nome para The Cannabist Company Holdings Inc. em setembro de 2023. A empresa foi fundada em 2012 e tem sede em Nova Iorque, Nova Iorque.

Nome
Cannabist Co. Holdings Aktie
CEO
Christopher Marr
Sede Malvern, pa
EUA
Site
Entrada em bolsa
29/04/2019
Colaboradores 2.829

Símbolos de ticker

Bolsa Símbolo
Neo
CBST.NE
Pnk
CBSTF
Frankfurt
VW5.F
Düsseldorf
VW5.DU
München
VW5.MU
🍪

Parqet  utiliza cookies. Saber mais